These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23715497)

  • 1. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
    Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
    Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women.
    Qi G; Xiong H; Zhou C
    Tumour Biol; 2014 Jun; 35(6):5723-6. PubMed ID: 24577894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common deletion in the APOBEC3 genes and breast cancer risk.
    Long J; Delahanty RJ; Li G; Gao YT; Lu W; Cai Q; Xiang YB; Li C; Ji BT; Zheng Y; Ali S; Shu XO; Zheng W
    J Natl Cancer Inst; 2013 Apr; 105(8):573-9. PubMed ID: 23411593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.
    Han Y; Qi Q; He Q; Sun M; Wang S; Zhou G; Sun Y
    Oncotarget; 2016 Nov; 7(46):74979-74986. PubMed ID: 27602762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3A/B deletion polymorphism and cancer risk.
    Gansmo LB; Romundstad P; Hveem K; Vatten L; Nik-Zainal S; Lønning PE; Knappskog S
    Carcinogenesis; 2018 Feb; 39(2):118-124. PubMed ID: 29140415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
    Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.
    Hashemi M; Moazeni-Roodi A; Taheri M
    Asia Pac J Clin Oncol; 2019 Dec; 15(6):275-287. PubMed ID: 30693645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
    Cai Q; Wen W; Qu S; Li G; Egan KM; Chen K; Deming SL; Shen H; Shen CY; Gammon MD; Blot WJ; Matsuo K; Haiman CA; Khoo US; Iwasaki M; Santella RM; Zhang L; Fair AM; Hu Z; Wu PE; Signorello LB; Titus-Ernstoff L; Tajima K; Henderson BE; Chan KY; Kasuga Y; Newcomb PA; Zheng H; Cui Y; Wang F; Shieh YL; Iwata H; Le Marchand L; Chan SY; Shrubsole MJ; Trentham-Dietz A; Tsugane S; Garcia-Closas M; Long J; Li C; Shi J; Huang B; Xiang YB; Gao YT; Lu W; Shu XO; Zheng W
    Cancer Res; 2011 Feb; 71(4):1344-55. PubMed ID: 21303983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
    Roelofs PA; Martens JWM; Harris RS; Span PN
    Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
    Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
    Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
    Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
    Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY
    J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.
    Zhao Z; Wen W; Michailidou K; Bolla MK; Wang Q; Zhang B; Long J; Shu XO; Schmidt MK; Milne RL; García-Closas M; Chang-Claude J; Lindstrom S; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Blomqvist C; Bogdanova NV; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Burwinkel B; Cai Q; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Harrington P; Hartman M; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; John EM; Johnson N; Kabisch M; Khan S; Kibriya M; Knight JA; Kosma VM; Kriege M; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Lophatananon A; Luben R; Lubinski J; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Miao H; Muir K; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Schoemaker M; Shah M; Shrubsole M; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Wang-Gohrke S; Whittemore AS; Winqvist R; Pilar Zamora M; Zhao H; Dunning AM; Simard J; Hall P; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
    Cancer Causes Control; 2016 May; 27(5):679-93. PubMed ID: 27053251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European ancestry is positively associated with breast cancer risk in Mexican women.
    Fejerman L; Romieu I; John EM; Lazcano-Ponce E; Huntsman S; Beckman KB; Pérez-Stable EJ; González Burchard E; Ziv E; Torres-Mejía G
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1074-82. PubMed ID: 20332279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
    Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
    Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.